Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 52 | 2024 | 8596 | 3.450 |
Why?
|
Amyloid beta-Peptides | 38 | 2024 | 3837 | 1.870 |
Why?
|
tau Proteins | 24 | 2024 | 2095 | 1.500 |
Why?
|
Neuropsychological Tests | 24 | 2024 | 7045 | 1.470 |
Why?
|
Amyloid | 7 | 2024 | 841 | 1.390 |
Why?
|
Positron-Emission Tomography | 40 | 2024 | 6485 | 1.270 |
Why?
|
Mental Recall | 5 | 2019 | 1214 | 0.940 |
Why?
|
Disease Progression | 15 | 2023 | 13502 | 0.840 |
Why?
|
Memory | 7 | 2023 | 2187 | 0.800 |
Why?
|
Thiazines | 1 | 2022 | 38 | 0.790 |
Why?
|
Executive Function | 7 | 2018 | 1389 | 0.790 |
Why?
|
Learning Curve | 1 | 2023 | 230 | 0.780 |
Why?
|
Memory Disorders | 7 | 2024 | 1198 | 0.780 |
Why?
|
Aging | 13 | 2024 | 8705 | 0.780 |
Why?
|
Locus Coeruleus | 6 | 2024 | 230 | 0.730 |
Why?
|
Cognition | 16 | 2024 | 6986 | 0.640 |
Why?
|
Aphasia, Primary Progressive | 1 | 2020 | 83 | 0.640 |
Why?
|
Aniline Compounds | 11 | 2024 | 1069 | 0.610 |
Why?
|
Cognition Disorders | 5 | 2014 | 3979 | 0.600 |
Why?
|
Brain | 22 | 2024 | 27107 | 0.570 |
Why?
|
Huntington Disease | 2 | 2012 | 1144 | 0.490 |
Why?
|
Cues | 2 | 2017 | 875 | 0.480 |
Why?
|
Aged | 62 | 2024 | 169235 | 0.460 |
Why?
|
Semantics | 2 | 2019 | 601 | 0.420 |
Why?
|
Remedial Teaching | 1 | 2012 | 16 | 0.420 |
Why?
|
Association Learning | 1 | 2014 | 221 | 0.410 |
Why?
|
Thiazoles | 10 | 2019 | 1517 | 0.400 |
Why?
|
Atrophy | 5 | 2024 | 1633 | 0.390 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 8000 | 0.380 |
Why?
|
Longitudinal Studies | 19 | 2024 | 14599 | 0.370 |
Why?
|
Apathy | 2 | 2024 | 107 | 0.360 |
Why?
|
Aged, 80 and over | 34 | 2024 | 58956 | 0.330 |
Why?
|
Amnesia | 1 | 2011 | 255 | 0.330 |
Why?
|
Names | 3 | 2020 | 54 | 0.320 |
Why?
|
Face | 2 | 2017 | 1026 | 0.320 |
Why?
|
Memory, Short-Term | 2 | 2012 | 982 | 0.320 |
Why?
|
Hippocampus | 6 | 2020 | 3763 | 0.320 |
Why?
|
Parietal Lobe | 2 | 2024 | 851 | 0.320 |
Why?
|
Psychomotor Performance | 4 | 2018 | 1879 | 0.310 |
Why?
|
Magnetic Resonance Imaging | 19 | 2024 | 36423 | 0.300 |
Why?
|
Educational Measurement | 1 | 2014 | 1254 | 0.280 |
Why?
|
Mental Status Schedule | 2 | 2017 | 314 | 0.250 |
Why?
|
Male | 53 | 2024 | 360736 | 0.250 |
Why?
|
Female | 55 | 2024 | 392581 | 0.250 |
Why?
|
Humans | 76 | 2024 | 761423 | 0.250 |
Why?
|
Tauopathies | 2 | 2019 | 320 | 0.230 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 151 | 0.220 |
Why?
|
Attention | 2 | 2024 | 2395 | 0.220 |
Why?
|
Cross-Sectional Studies | 13 | 2024 | 26112 | 0.220 |
Why?
|
Psychotherapy | 1 | 2012 | 1647 | 0.210 |
Why?
|
Entorhinal Cortex | 3 | 2023 | 287 | 0.200 |
Why?
|
Temporal Lobe | 5 | 2024 | 1695 | 0.190 |
Why?
|
Apolipoprotein E4 | 4 | 2019 | 708 | 0.190 |
Why?
|
Feasibility Studies | 2 | 2023 | 5246 | 0.190 |
Why?
|
Frontal Lobe | 2 | 2024 | 1420 | 0.180 |
Why?
|
Depressive Disorder | 1 | 2012 | 3728 | 0.170 |
Why?
|
Australia | 2 | 2022 | 1250 | 0.170 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 115 | 0.170 |
Why?
|
Corpus Striatum | 2 | 2018 | 1235 | 0.160 |
Why?
|
Midwifery | 1 | 2020 | 124 | 0.160 |
Why?
|
Computers | 1 | 2021 | 594 | 0.150 |
Why?
|
Presenilin-1 | 2 | 2020 | 660 | 0.150 |
Why?
|
Psychometrics | 2 | 2019 | 3065 | 0.140 |
Why?
|
Reaction Time | 1 | 2023 | 2080 | 0.140 |
Why?
|
Depression | 2 | 2017 | 8122 | 0.140 |
Why?
|
Robotics | 1 | 2023 | 819 | 0.130 |
Why?
|
Advisory Committees | 1 | 2021 | 786 | 0.130 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 759 | 0.130 |
Why?
|
Activities of Daily Living | 3 | 2023 | 2421 | 0.130 |
Why?
|
Empathy | 1 | 2020 | 473 | 0.130 |
Why?
|
Neural Pathways | 3 | 2024 | 3057 | 0.120 |
Why?
|
Middle Aged | 25 | 2024 | 220826 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1474 | 0.120 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2727 | 0.110 |
Why?
|
Mental Disorders | 1 | 2012 | 6841 | 0.100 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5776 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 710 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20093 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1474 | 0.100 |
Why?
|
Amyloidosis | 1 | 2018 | 817 | 0.090 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2012 | 247 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10203 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2015 | 748 | 0.090 |
Why?
|
Boston | 1 | 2023 | 9330 | 0.090 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 587 | 0.090 |
Why?
|
Tai Ji | 1 | 2014 | 289 | 0.090 |
Why?
|
Problem Solving | 1 | 2012 | 441 | 0.090 |
Why?
|
Qualitative Research | 1 | 2021 | 3023 | 0.090 |
Why?
|
Nerve Net | 2 | 2024 | 2288 | 0.090 |
Why?
|
Pyridines | 1 | 2022 | 2875 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2024 | 12330 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15838 | 0.080 |
Why?
|
Latin America | 2 | 2020 | 410 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39117 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2010 | 0.080 |
Why?
|
Colombia | 2 | 2019 | 279 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6922 | 0.070 |
Why?
|
Carbolines | 2 | 2019 | 296 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2651 | 0.070 |
Why?
|
Ethylene Glycols | 2 | 2019 | 190 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3429 | 0.060 |
Why?
|
Life Style | 2 | 2023 | 3914 | 0.060 |
Why?
|
Learning | 1 | 2014 | 1740 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 939 | 0.060 |
Why?
|
Trust | 1 | 2009 | 530 | 0.060 |
Why?
|
Cognitive Reserve | 1 | 2024 | 92 | 0.060 |
Why?
|
Neurogranin | 1 | 2022 | 15 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9612 | 0.050 |
Why?
|
Repression, Psychology | 1 | 2022 | 46 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2686 | 0.050 |
Why?
|
Informed Consent | 1 | 2009 | 1008 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.050 |
Why?
|
Attitude to Health | 1 | 2009 | 2025 | 0.040 |
Why?
|
European Union | 1 | 2021 | 157 | 0.040 |
Why?
|
Culture | 1 | 2023 | 623 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2690 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 46 | 0.040 |
Why?
|
Palmitates | 1 | 2017 | 70 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17912 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 6019 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54415 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5311 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9179 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 999 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2017 | 209 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10548 | 0.030 |
Why?
|
Adult | 7 | 2021 | 221148 | 0.030 |
Why?
|
Tongue | 1 | 2017 | 403 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 942 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 8633 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 30045 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 761 | 0.030 |
Why?
|
Skin Diseases, Infectious | 1 | 2012 | 76 | 0.030 |
Why?
|
Self Report | 1 | 2024 | 3724 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2520 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14664 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2018 | 1115 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1443 | 0.020 |
Why?
|
Interleukin-23 | 1 | 2012 | 201 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1385 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3564 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2012 | 583 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2022 | 5115 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 41446 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3335 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.020 |
Why?
|
Drug and Narcotic Control | 1 | 2009 | 144 | 0.020 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 560 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1404 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5884 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1126 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 29620 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7825 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3356 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2009 | 726 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6626 | 0.010 |
Why?
|
Drug Industry | 1 | 2009 | 788 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13255 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2022 | 64651 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74167 | 0.010 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15498 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168441 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8999 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15941 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29862 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4021 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20556 | 0.010 |
Why?
|
Caregivers | 1 | 2009 | 2237 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15717 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80582 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5819 | 0.010 |
Why?
|
United States | 1 | 2021 | 72339 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59207 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88313 | 0.010 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(54)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_